Palvella Therapeutics Appoints John D. Doux to Board
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) recently appointed John D. Doux, M.D., M.B.A., to its board of directors as the company advances its pipeline of treatments for rare …
Palvella Therapeutics Appoints John D. Doux to Board Read More